Orforglipron was discovered by Chugai Pharmaceutical and licensed by Lilly in 2018
Tirzepatide works by copying the action of two natural hormones in your body that control metabolism
Improved sleep quality leads to better physical performance, enhanced cognitive function, and greater emotional well-being
Biomarker Context: What to Assess Before Starting GLP-1 Therapy Before initiating GLP-1 therapy, baseline kidney biomarkersincluding serum creatinine, eGFR, uric acid, and 24-hour urine calcium and citrateprovide essential context for individual risk
In the SURMOUNT-1 trials, the tirzepatide group lost about 20.2% of baseline body weight in 72 weeks, while the semaglutide group lost about 13.7 %
Obesity Pillars, 12, 100127